Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
24 Jun 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Laparoscopic versus open resection for colorectal liver metastases ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer
Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer ( Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK )
11 Jun 2019
Managing metastatic breast cancer and beyond using PARP inhibitors
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Managing metastatic breast cancer and beyond using PARP inhibitors ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherap...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Sp...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )
3 Jun 2019
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA ge...
Dr Hedy Kindler - University of Chicago, Chicago, USA
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA gene mutations ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Maintenance therapy with PARP inhibitor olaparib delays progression in patients ...
Dr Hedy Kindler - University of Chicago, Chicago, USA
Maintenance therapy with PARP inhibitor olaparib delays progression in patients with BRCA-related pancreatic cancer ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients...
Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients allowing them to be treated with an oral agent ( Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA )
2 Jun 2019
Epigenetic expression in T cell leukaemia
Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA
Epigenetic expression in T cell leukaemia ( Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA )
24 May 2019